Clinical management of inflammatory bowel disease in the organ recipient

Table 1 Interaction between inflammatory bowel disease therapy and anti-reject therapy in inflammatory bowel disease patients after liver transplantation

Drug	Efficacy		Ref.
	IBD therapy	Anti-reject therapy
5-ASA	+		[3]
			[12]
Prednisone	+	+	[12]
			[21]
Azathioprine	+	+	[2]
Anti-TNFα	+		[15]
			[16]
			[13]
			[14]
			[18]
Tacrolimus	-	+	[2]
			[3]
Cyclosporine	+	+	[3]
Mycophenolate	-	+	[22]
Mofetil			[23]

TNFα: Tumor necrosis factor alpha; IBD: Inflammatory bowel disease; 5-ASA: 5-aminosalicylates.